GG540 Pill — WHITE CAPSULE, 16mm — Fluoxetine
| Imprint | GG540 |
|---|---|
| Colour | WHITE |
| Shape | CAPSULE |
| Size | 16 |
| Strength | FLUOXETINE HYDROCHLORIDE 40 mg |
| Dosage form | Capsule |
| Manufacturer | Sandoz Inc |
| NDC | 0781-2824 |
| Schedule | — |
| Availability | — |
| Ingredients | FLUOXETINE HYDROCHLORIDE[FLUOXETINE] |
What does this imprint mean?
The imprint "GG540" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Fluoxetine
Uses and warnings
BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc
Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---
How to identify this pill
- • Check the imprint matches exactly: "GG540".
- • Confirm the colour (WHITE) and shape (CAPSULE).
- • Compare the size (16) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
L402
WHITE CAPSULE · Acetaminophen
L374
WHITE CAPSULE · Acetaminophen
54 463
WHITE CAPSULE · Lithium
Q10
WHITE CAPSULE · Potassium Chloride
8I
WHITE CAPSULE · Ibuprofen
66 D
WHITE CAPSULE · Azithromycin
C5 100mg
WHITE CAPSULE · Celecoxib
WW928
WHITE CAPSULE · Ciprofloxacin
122
WHITE CAPSULE · Ibuprofen
300
WHITE CAPSULE · Quetiapine
WW928
WHITE CAPSULE · Ciprofloxacin
HP65
WHITE CAPSULE · Metronidazole
Other pills of Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
PLIVA 647
WHITE CAPSULE · Fluoxetine
FL 20
WHITE OVAL · Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
E 88
GREEN CAPSULE · Fluoxetine
R 0150
BLUE OVAL · Fluoxetine
FL 20
WHITE OVAL · Fluoxetine
566 20
WHITE OVAL · Fluoxetine
PLIVA 647
WHITE CAPSULE · Fluoxetine
DISTA 3105
YELLOW;GREEN CAPSULE · Fluoxetine
RX632
GREEN CAPSULE · Fluoxetine
PLIVA 648
WHITE;GREEN CAPSULE · Fluoxetine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 1c89f15b-eefd-4be2-9055-1374a76669cd.xml